Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05059262
Title Phase 3 Study of Vimseltinib for Tenosynovial Giant Cell Tumor (MOTION)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

No variant requirements are available.